Showing results (161-170 of 335) with videos related to
Sort By:
Pageof 34
Oncology Letters|September 26, 2017
Measurement of exhaled nitric oxide and serum surfactant protein D levels for monitoring radiation pneumonitis following thoracic radiotherapyHideya Yamazaki, Norihiro Aibe, Satoaki Nakamura, et al.European Journal of Cancer (Oxford, England : 1990)|October 27, 2023
A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT studyTadaaki Yamada, Yasuhiro Goto, Hiroshi Tanaka, et al.Thoracic Cancer|November 18, 2021
Impact of docetaxel plus ramucirumab in a second-line setting after chemoimmunotherapy in patients with non-small-cell lung cancer: A retrospective studyMasaki Ishida, Kenji Morimoto, Tadaaki Yamada, et al.Cancer Chemotherapy and Pharmacology|October 30, 2013
Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401Koichi Takayama, Koji Inoue, Shoji Tokunaga, et al.Medical Oncology (Northwood, London, England)|March 18, 2018
Predictive factors in patients eligible for pegfilgrastim prophylaxis focusing on RDI using ordered logistic regression analysisYuko Kanbayashi, Takeshi Ishikawa, Motohiro Kanazawa, et al.Anticancer Research|October 3, 2022
Efficacy and Safety of Paclitaxel/nab-paclitaxel Chemotherapy for Patients With Relapsed Small Cell Lung CancerYohei Matsui, Tadaaki Yamada, Kenji Morimoto, et al.Journal of Clinical Medicine|January 8, 2020
Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung CancerYuki Katayama, Takayuki Shimamoto, Tadaaki Yamada, et al.American Journal of Surgery|March 26, 2008
Optimization of conditionally replicative adenovirus for pancreatic cancer and its evaluation in an orthotopic murine xenograft modelPedro J Ramírez, Selwyn M Vickers, Hidetaka A Ono, et al.Respirology (Carlton, Vic.)|January 17, 2008
Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancerKoichi Takayama, Masayuki Kawasaki, Kiyoshi Ninomiya, et al.Molecular Cancer Therapeutics|October 6, 2023
Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma CellsSoichi Hirai, Tadaaki Yamada, Yuki Katayama, et al.Pageof 34